Yukishige Kimura

591 total citations
13 papers, 465 citations indexed

About

Yukishige Kimura is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, Yukishige Kimura has authored 13 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Yukishige Kimura's work include Pancreatic function and diabetes (5 papers), Autophagy in Disease and Therapy (3 papers) and Diabetes Treatment and Management (3 papers). Yukishige Kimura is often cited by papers focused on Pancreatic function and diabetes (5 papers), Autophagy in Disease and Therapy (3 papers) and Diabetes Treatment and Management (3 papers). Yukishige Kimura collaborates with scholars based in Japan. Yukishige Kimura's co-authors include Tetsuji Miura, Takayuki Miki, Masaya Tanno, Toshiyuki Yano, Atsushi Kuno, Tatsuya Sato, Kei Nakata, H Oshima, Masashi Mizuno and Koki Abe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yukishige Kimura

12 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukishige Kimura Japan 10 246 221 157 93 71 13 465
Xuesi Wan China 14 162 0.7× 174 0.8× 120 0.8× 39 0.4× 54 0.8× 23 438
Raphaela P. Kerindongo Netherlands 11 171 0.7× 126 0.6× 139 0.9× 92 1.0× 22 0.3× 14 429
Domenico Cerullo Italy 10 139 0.6× 152 0.7× 111 0.7× 50 0.5× 44 0.6× 25 428
Na Zhou China 13 82 0.3× 277 1.3× 67 0.4× 124 1.3× 87 1.2× 35 537
Caroline Rudnicka Australia 10 310 1.3× 184 0.8× 168 1.1× 154 1.7× 63 0.9× 13 519
Rodolfo Nasti Italy 9 115 0.5× 134 0.6× 100 0.6× 126 1.4× 32 0.5× 14 422
Tae Sik Jung South Korea 13 297 1.2× 80 0.4× 206 1.3× 49 0.5× 71 1.0× 38 531
Camille Marciniak France 10 81 0.3× 103 0.5× 102 0.6× 92 1.0× 68 1.0× 27 332
Suzanne B. Brown United States 8 157 0.6× 141 0.6× 124 0.8× 191 2.1× 94 1.3× 9 514
Yunshan Hu Australia 7 301 1.2× 160 0.7× 116 0.7× 95 1.0× 28 0.4× 7 396

Countries citing papers authored by Yukishige Kimura

Since Specialization
Citations

This map shows the geographic impact of Yukishige Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukishige Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukishige Kimura more than expected).

Fields of papers citing papers by Yukishige Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukishige Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukishige Kimura. The network helps show where Yukishige Kimura may publish in the future.

Co-authorship network of co-authors of Yukishige Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Yukishige Kimura. A scholar is included among the top collaborators of Yukishige Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukishige Kimura. Yukishige Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Takahashi, Tomokazu, et al.. (2023). IgG4-Related Pericarditis Diagnosed by Accumulated Pericardial Effusion. SHILAP Revista de lepidopterología. 2023. 1–8.
2.
Moniwa, Norihito, Atsushi Kuno, Wataru Ohwada, et al.. (2020). Activation of the angiotensin II receptor promotes autophagy in renal proximal tubular cells and affords protection from ischemia/reperfusion injury. Journal of Pharmacological Sciences. 145(2). 187–197. 12 indexed citations
3.
Kuno, Atsushi, Yukishige Kimura, Masashi Mizuno, et al.. (2020). Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats. Scientific Reports. 10(1). 7238–7238. 29 indexed citations
4.
Sato, Tatsuya, Toshiyuki Yano, Yukishige Kimura, et al.. (2020). Protective effect of treatment with a continuous erythropoietin receptor activator on CKD-induced myocardial intolerance to ischemia/reperfusion injury is lost by use of its excessive dose. Journal of Molecular and Cellular Cardiology. 140. 41–42. 1 indexed citations
5.
Abe, Koki, Toshiyuki Yano, Masaya Tanno, et al.. (2019). mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(12). 165552–165552. 46 indexed citations
6.
Kimura, Yukishige, Atsushi Kuno, Masaya Tanno, et al.. (2019). Canagliflozin, a sodium–glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats. Journal of Diabetes Investigation. 10(4). 933–946. 44 indexed citations
7.
Oshima, H, Takayuki Miki, Atsushi Kuno, et al.. (2018). Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 368(3). 524–534. 103 indexed citations
8.
Sato, Tatsuya, H Oshima, Kei Nakata, et al.. (2018). Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes. Journal of Diabetes Investigation. 10(3). 846–850. 27 indexed citations
9.
Mizuno, Masashi, Atsushi Kuno, Toshiyuki Yano, et al.. (2018). Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts. Physiological Reports. 6(12). e13741–e13741. 139 indexed citations
10.
Kuno, Atsushi, Masaya Tanno, Takayuki Miki, et al.. (2017). Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes. Scientific Reports. 7(1). 5311–5311. 29 indexed citations
11.
Yano, Toshiyuki, Masaya Tanno, Takayuki Miki, et al.. (2017). Insufficient activation of Akt upon reperfusion because of its novel modification by reduced PP2A-B55α contributes to enlargement of infarct size by chronic kidney disease. Basic Research in Cardiology. 112(3). 31–31. 21 indexed citations
12.
Tanaka, Marenao, Norihito Moniwa, Hirofumi Ohnishi, et al.. (2017). Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study. Kidney & Blood Pressure Research. 42(3). 553–564. 1 indexed citations
13.
Kouzu, Hidemichi, Takayuki Miki, Masashi Mizuno, et al.. (2013). Inflammatory Myofibroblastic Tumor of the Heart. Circulation Journal. 78(4). 1006–1008. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026